Myocardial flow reserve

Biomarker

2 papers1 finding

  • Human trial1
  • Humans1

Interventions

1

Luseogliflozin

no changein humans1

1 study
  1. Luseogliflozin has no effect on myocardial flow reserve in humans (2.26 ± 0.38 vs 2.35 ± 0.55 p = 0.464).

    “There was no significant change in MFR in the luseogliflozin group”

    Human trialpatients with type 2 diabetes24 weeksn = 33

    Effect of Luseogliflozin on Myocardial Flow Reserve in Patients with Type 2 Diabetes Mellitus (LUCENT-J Study)

    ADA Scientific Sessions 2026 abstract5 Jun 2026

More on Luseogliflozin

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 1Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 23 in 12 months
medRxiv

Main artery calcium linked to risk despite normal heart scans

Higher calcium in the main artery was linked to cardiovascular death, heart attack or heart failure admission in 3,580 patients followed for a median 52 months.Higher calcium in the main artery was linked to cardiovascular death, heart attack or heart failure admission in 3,580 patients followed for a median 52 months.

Preprint: cohort study of 21,923 peopleBiomarkers